NCT02902757 2025-12-17FDG PET/CT in Monitoring Very Early Therapy Response in Patients With GlioblastomaJonsson Comprehensive Cancer CenterPhase NA Completed7 enrolled
NCT06815029 2025-06-26Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant AstrocytomaCity of Hope Medical CenterPhase 1 Recruiting27 enrolled